Video yükleniyor...
Video Yüklenemedi
Today we announced our initial post-approval access plans for our investigational HIV pre-exposure prophylaxis (PrEP). We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can quickly reach those who need it in low- and middle-income countries. Learn more:
13,686 görüntüleme • 11 gün önce •via X (Twitter)
0 Yorum
Yorum bulunmuyor
Orijinal gönderinin yorumları burada görünecek






